FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

703871000168104: Temozolomide (Apo) (temozolomide 20 mg) capsule (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2015. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2439871000168119 Temozolomide (Apo) (temozolomide 20 mg) capsule (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2439881000168116 Temozolomide (Apo) 20 mg capsule en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Temozolomide (Apo) 20 mg capsule has manufactured dose form capsule true Inferred relationship Some
Temozolomide (Apo) 20 mg capsule has intended active ingredient temozolomide true Inferred relationship Some 1882503680
Temozolomide (Apo) 20 mg capsule Is a trade product unit of use true Inferred relationship Some
Temozolomide (Apo) 20 mg capsule Is a Temozolomide (Apo) true Inferred relationship Some
Temozolomide (Apo) 20 mg capsule Is a temozolomide 20 mg capsule true Inferred relationship Some
Temozolomide (Apo) 20 mg capsule has manufactured dose form hard capsule false Inferred relationship Some
Temozolomide (Apo) 20 mg capsule has unit of use capsule true Inferred relationship Some 1882503681
Temozolomide (Apo) 20 mg capsule has Australian BoSS temozolomide true Inferred relationship Some 1882503680

Inbound Relationships Type Active Source Characteristic Refinability Group
Temozolomide (Apo) (temozolomide 20 mg) capsule, 5 capsules, bottle (containered trade product pack) has TPUU True Temozolomide (Apo) 20 mg capsule Inferred relationship Some 1
Temozolomide (Apo) 20 mg capsule, 5 has TPUU True Temozolomide (Apo) 20 mg capsule Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start